Source: International Congress 2014 – COPD exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bafadhel, L. Davies, P. Calverley, S. Aaaron, C. Brightling, I. Pavord (Oxford, Liverpool, Leicester, United Kingdom; Ottawa, Canada). Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis. Eur Respir J 2014; 44: Suppl. 58, 1937

Member's Comments

No comment yet.

Related content which might interest you: Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Can red blood cell morphology be an indicator for COPD exacerbations? Source: International Congress 2014 – Markers Year: 2014 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Microbiological indicators from sputum of patients with exacerbation of COPD Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Blood eosinophils and outcomes in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Assessment of malondialdehyde in the airways during treatment of COPD exacerbations Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Role of activated complement in COPD exacerbation recovery Source: International Congress 2014 – Comorbidities Year: 2014 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 LATE-BREAKING ABSTRACT: beta-blockers are associated with a reduction in COPD exacerbations in COPDGene Source: International Congress 2014 – COPD exacerbations Year: 2014 Impact of mucolytic treatment on COPD exacerbations Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis Source: Eur Respir J 2014; 44: 789-791 Year: 2014 A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014